Wave Life Sciences Ltd. (NASDAQ:WVE) is among the 12 Best Genomics Stocks to Invest In. H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE) TheFly reports that on December 19, 2025, H.C. Wainwright upgraded Wave Life Sciences Ltd. (NASDAQ:WVE)’s price target from $22 to$30. Analyst Andrew Fein upheld the Buy rating. H.C. Wainwright cited 9.4% visceral fat loss and 3.2% lean mass gain with no gastrointestinal problems to support WVE-007 as a possible body recomposition agent, using ke ...